[1] 陈文浩,何立群.肾缺血再灌注损伤机制及保护研究进展[J]. 世界中医药,2019,14:1068-1073. [2] Xie Y, Xiao J, Fu C, et al. Ischemic preconditioning promotes autophagy and alleviates renal ischemia/reperfusion injury[J]. Biomed Res Int,2018,2018:8353987. doi: 10.1155/2018/8353987. [3] 杨艳丽,蔡昌兰,顾苡铭.白藜芦醇抗癌的生物学机制研究进展[J]. 现代肿瘤医学,2020,28:338-341. [4] Baltaci AK, Gokbudak H, Baltaci SB, et al. The effects of resveratrol administration on lipid oxidation in experimental renal ischemia-reperfusion injury in rats[J]. Biotech Histochem,2019,94:592-599. [5] 宋玲玲,黄婷,陈志娥,等. 白藜芦醇对糖尿病大鼠肾缺血再灌注损伤的影响[J]. 武汉大学学报(医学版),2020,41:183-187. [6] Chen J, Stark LA. Insights into the relationship between nucleolar stress and the NF-κB pathway[J]. Trends Genet,2019,35:768-780. [7] 张敬,令狐瑞琦,沙晶晶,等. NF-κB信号转导通路与复发性口腔溃疡的相关性分析[J]. 上海口腔医学,2018,27:513-517. [8] Haberal M, Boyvat F, Akdur A, et al. Surgical complications after kidney transplantation[J]. Exp Clin Transplant,2016,14:587-595. [9] Malek M, Nematbakhsh M. Renal ischemia/reperfusion injury; from pathophysiology to treatment[J]. J Renal Inj Prev,2015,4:20-27. [10] Albertoni G, Schor N. Resveratrol plays important role in protective mechanisms in renal disease--mini-review[J]. J Bras Nefrol, 2015,37:106-114. [11] Campbell KJ, Tait SWG. Targeting BCL-2 regulated apoptosis in cancer[J]. Open Biol,2018,8:180002. doi: 10.1098/rsob.180002. [12] 黄艳艳,何庭艳,夏宇,等.新发A20单倍剂量不足一例临床表型及免疫功能研究[J]. 中华儿科杂志,2020,58:218-222. [13] 梁冬冬,刘少奎,高新宇,等. 白藜芦醇抑制血管紧张素Ⅱ/TLR4/NF-KB调控鼠血管平滑肌细胞炎症和氧化应激损伤作用[J]. 中国循证心血管医学杂志,2019,11:1461-1463,1467. |